1741 - 1750 of 8571 Results
Title
Year
-
OPENTitle: FLED: a full-length eccDNA detector for long-reads sequencing dataJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 24Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bib/bbad388Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10632013Citation Count: 9
- Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease2011OPENTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Best OA location URL: https://europepmc.org/articles/pmc3058704Citation Count: 129
- Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model2025RESTRICTEDTitle: Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat modelJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 20Issue #: 8Start Page: e0329823End Page: e0329823Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0329823Best OA location URL: https://doi.org/10.1371/journal.pone.0329823Citation Count: 0
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 18
-
OPENTitle: Hsp110 mitigates α-synuclein pathology in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 48Start Page: 24310End Page: 24316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1903268116Best OA location URL: https://www.pnas.org/content/pnas/116/48/24310.full.pdfCitation Count: 53
- Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease2018OPENTitle: Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington diseaseJournal Name: BMC Medical Informatics and Decision MakingPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12911-018-0714-7Best OA location URL: https://bmcmedinformdecismak.biomedcentral.com/track/pdf/10.1186/s12911-018-0714-7Citation Count: 39
-
OPENTitle: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteinsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00564-3Best OA location URL: https://www.nature.com/articles/s41531-023-00564-3.pdfCitation Count: 19
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.13130Citation Count: 3
- Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease2010RESTRICTEDTitle: Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson DiseaseJournal Name: ChestPublisher: Elsevier BVVol: 138Issue #: 6Start Page: 1426End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1378/chest.10-0342Citation Count: 88